Article of the Year

Which Publication Will Be Crowned the 2025 EBNEO Impact Article of the Year?

After a highly competitive first round involving eight outstanding articles, two finalists have risen to the top. While the margin was incredibly narrow, Faix et al. and Laughon et al. are our clear frontrunners. We are now opening one final head-to-head vote to determine the definitive Impact Article of the Year. Choose your winner below.

The vote is open for 5 days. Please note that all voting is monitored; repeat votes or automated entries will be removed to ensure a fair result.

Round of 8 Vote!

The EBNEO Impact Article of the Year (IAOTY) celebrates research that shapes neonatal practice and sparks global discussion. From the Impact Article of the Month (IAOTM), EBNEO editors have selected the eight most impactful articles of 2025, and now it’s the community’s turn to decide which study stands out. The public vote is open for seven days, and the two articles with the highest votes will advance to the final round, where the neonatal community will select the ultimate IAOTY winner. Only one vote per participant is allowed; multiple votes will be monitored and removed. This award reflects not only scientific excellence but also the voices and priorities of clinicians worldwide, true to EBNEO’s mission of making evidence-based neonatology both accessible and impactful.

Which 2025 publication will have the most impact on neonatal care?

Follow the links below to each publication. Poll will close on April 6 noon time GMT. The publications were arranged in alphabetical order. Please select the top 2 finalists.

 

2024 Final Results

 

2024 Round of 8 Vote!

 

Past Results

The 2023 EBNEO Impact Article of the Year Winner:

Kidman et al. Higher versus lower nasal continuous positive airway pressure for extubation of extremely preterm infants in Australia (ÉCLAT): a multicentre, randomised, superiority trial – Lancet Child Adol. 2023; 7(12): 844 – 851

This poll is no longer accepting votes

Which 2023 publication will have the most impact on neonatal care? Follow each link to the article!

Nominees:

Hansen et al. Cerebral Oximetry Monitoring in Extremely Preterm Infants. NEJM. 2023;388:1501-1511

Kampmann et al. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. NEJM. 2023;388:1451-1464

Katheria et al. Umbilical Cord Milking Versus Delayed Cord Clamping in Infants 28 to 32 Weeks: A Randomized Trial – Pediatrics. 2023;152 (6): e2023063113

Kidman et al. Higher versus lower nasal continuous positive airway pressure for extubation of extremely preterm infants in Australia (ÉCLAT): a multicentre, randomised, superiority trial – Lancet Child Adol. 2023; 7(12): 844 – 851

Marshall et al. Assessment of infant position and timing of stylet removal to improve lumbar puncture success in neonates (NeoCLEAR): an open-label, 2 × 2 factorial, randomised, controlled trial – Lancet Child Adol. 2023;7(2): 91 – 100

Moore et al. Two-year outcomes following a randomised platelet transfusion trial in preterm infants – ADC F&N.

Salas et al. Early Human Milk Fortification in Infants Born Extremely Preterm: A Randomized Trial – Pediatrics. 2023; 152 (3): e2023061603

Young et al. Eat, Sleep, Console Approach or Usual Care for Neonatal Opioid Withdrawal – NEJM. 2023;388:2326-2337

The 2022 EBNEO Impact Article of the Year

EBNEO.AOTY_1_03_24

Bloomfield FH, Jiang Y, Harding JE, et al. Early Amino Acids in Extremely Preterm Infants and Neurodisability at 2 Years. NEJM. 2022; 387:1661-1672.

Hammitt LL, Dagan R, Yuan Y, et al. Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants. NEJM. 2022; 386:837-846.

Hodgson KA, Owen LS, Kamlin OF, et al. Nasal High-Flow Therapy during Neonatal Endotracheal Intubation. NEJM. 2022; 386:1627-1637.

Hundscheid T, Onland W, Kooi EMW, et al. Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus. NEJM. 2023; 388:980-990

Gallup JA, Ndakor SM, Pazzano C, et al. Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in neonates born preterm. J Pediatr. 2023; 254:17-24

Watterberg KL, Walsh MC, Chawla S, et al. Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia. NEJM. 2022; 386:1121-1131

WHO ACTION Collaborators. Antenatal dexamethasone for late preterm birth: A multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial. eClinicalMedicine. 2022; 44:101285

Wu YW, Comstock BA, Gonzalez FF, et al. Trial of Erythropoietin for Hypoxic–Ischemic Encephalopathy in Newborns. NEJM. 2022; 387:148-159

The 2021 EBNEO Impact Article of the Year

EBNEO.AOTY21.12.15

 

 

css.php